Sonoma Pharmaceuticals, Inc. financial data

Symbol
SNOA on Nasdaq
Location
Boulder, CO
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2025 - 10 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 288% % -15%
Quick Ratio 80% % 2.5%
Debt-to-equity 256% % 58%
Return On Equity -86% % -22%
Return On Assets -24% % 10%
Operating Margin -16% % 51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,730,613 shares 7.1%
Common Stock, Shares, Outstanding 1,730,613 shares 7.1%
Entity Public Float $4,047,199 USD 6.6%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 1,713,000 shares 17%
Weighted Average Number of Shares Outstanding, Diluted 1,713,000 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $17,722,000 USD 27%
Revenue from Contract with Customer, Excluding Assessed Tax $17,722,000 USD 27%
Cost of Revenue $2,699,000 USD 18%
Research and Development Expense $2,137,000 USD 18%
Operating Income (Loss) $2,766,000 USD 38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,450,000 USD 7.7%
Income Tax Expense (Benefit) $80,000 USD -900%
Net Income (Loss) Attributable to Parent $3,370,000 USD 10%
Earnings Per Share, Basic -1.79 USD/shares 68%
Earnings Per Share, Diluted -1.79 USD/shares 68%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,561,000 USD -51%
Accounts Receivable, after Allowance for Credit Loss, Current $2,382,000 USD -0.96%
Inventory, Net $3,703,000 USD 18%
Assets, Current $12,145,000 USD -1.9%
Deferred Income Tax Assets, Net $458,000 USD -40%
Property, Plant and Equipment, Net $314,000 USD 46%
Operating Lease, Right-of-Use Asset $642,000 USD 439%
Other Assets, Noncurrent $64,000 USD -12%
Assets $13,623,000 USD -0.33%
Accounts Payable, Current $1,646,000 USD 18%
Employee-related Liabilities, Current $1,737,000 USD 22%
Liabilities, Current $4,217,000 USD 14%
Operating Lease, Liability, Noncurrent $509,000 USD 1655%
Liabilities $10,191,000 USD 16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,191,000 USD 30%
Retained Earnings (Accumulated Deficit) $200,400,000 USD -1.7%
Stockholders' Equity Attributable to Parent $3,432,000 USD -30%
Liabilities and Equity $13,623,000 USD -0.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,015,000 USD -121%
Net Cash Provided by (Used in) Financing Activities $58,000 USD -109%
Net Cash Provided by (Used in) Investing Activities $106,000 USD -2020%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 1,730,613 shares 7.1%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,769,000 USD -228%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,561,000 USD -51%
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,000 USD -40%
Deferred Tax Assets, Valuation Allowance $29,062,000 USD -5.8%
Deferred Tax Assets, Gross $29,753,000 USD -7.4%
Operating Lease, Liability $655,000 USD 450%
Payments to Acquire Property, Plant, and Equipment $106,000 USD 2020%
Lessee, Operating Lease, Liability, to be Paid $812,000 USD 534%
Property, Plant and Equipment, Gross $2,300,000 USD -16%
Operating Lease, Liability, Current $146,000 USD 62%
Lessee, Operating Lease, Liability, to be Paid, Year Two $208,000 USD 1386%
Lessee, Operating Lease, Liability, to be Paid, Year One $210,000 USD 223%
Operating Lease, Weighted Average Discount Rate, Percent 0.106 pure 77%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $157,000 USD 1644%
Lessee, Operating Lease, Liability, to be Paid, Year Three $169,000 USD 2012%
Deferred Tax Assets, Operating Loss Carryforwards $26,456,000 USD -7.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 714,286 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $162,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $36,000 USD -7.7%
Deferred Tax Assets, Net of Valuation Allowance $691,000 USD -47%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%